BTIG analyst David Larsen upgraded Progyny (PGNY) to Buy from Neutral with a $28 price target
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PGNY:
- Progyny launches Parent and Child Well-being Offering
- Progyny’s Promising Growth Amidst Uncertainty: Hold Rating Maintained
- Progyny, Inc. Reports Strong 2024 Earnings with Optimistic Outlook
- Progyny’s Strong Q4 Results Amid Competitive Challenges and Uncertain Demand: Hold Rating Maintained
- Progyny price target raised to $34 from $30 at BofA